Literature DB >> 3384669

A general health policy model: update and applications.

R M Kaplan1, J P Anderson.   

Abstract

This article describes the development of a General Health Policy Model that can be used for program evaluation, population monitoring, clinical research, and policy analysis. An important component of the model, the Quality of Well-being scale (QWB) combines preference-weighted measures of symptoms and functioning to provide a numerical point-in-time expression of well-being, ranging from 0 for death to 1.0 for asymptomatic optimum functioning. The level of wellness at particular points in time is governed by the prognosis (transition rates or probabilities) generated by the underlying disease or injury under different treatment (control) variables. Well-years result from integrating the level of wellness, or health-related quality of life, over the life expectancy. Several issues relevant to the application of the model are discussed. It is suggested that a quality of life measure need not have separate components for social and mental health. Social health has been difficult to define; social support may be a poor criterion for resource allocation; and some evidence suggests that aspects of mental health are captured by the general measure. Although it has been suggested that measures of child health should differ from those used for adults, we argue that a separate conceptualization of child health creates new problems for policy analysis. After offering several applications of the model for the evaluation of prevention programs, we conclude that many of the advantages of general measures have been overlooked and should be given serious consideration in future studies.

Entities:  

Mesh:

Year:  1988        PMID: 3384669      PMCID: PMC1065501     

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  25 in total

1.  Health status: types of validity and the index of well-being.

Authors:  R M Kaplan; J W Bush; C C Berry
Journal:  Health Serv Res       Date:  1976       Impact factor: 3.402

2.  Rehabilitation of patients with chronic obstructive pulmonary disease.

Authors:  M M Lertzman; R M Cherniack
Journal:  Am Rev Respir Dis       Date:  1976-12

3.  Maximizing health system output with political and administrative constraints using mathematical programming.

Authors:  M M Chen; J W Bush
Journal:  Inquiry       Date:  1976-09       Impact factor: 1.730

4.  The sickness impact profile: validation of a health status measure.

Authors:  M Bergner; R A Bobbitt; W E Pollard; D P Martin; B S Gilson
Journal:  Med Care       Date:  1976-01       Impact factor: 2.983

5.  Policy space areas and properties of benefit-cost/utility analysis.

Authors:  J P Anderson; J W Bush; M Chen; D Dolenc
Journal:  JAMA       Date:  1986-02-14       Impact factor: 56.272

6.  Methods for measuring levels of well-being for a health status index.

Authors:  D L Patrick; J W Bush; M M Chen
Journal:  Health Serv Res       Date:  1973       Impact factor: 3.402

7.  Selection of an exercise program for patients with chronic obstructive pulmonary disease.

Authors:  K M Unger; K M Moser; P Hansen
Journal:  Heart Lung       Date:  1980 Jan-Feb       Impact factor: 2.210

8.  Innovation and evaluation.

Authors:  F Mosteller
Journal:  Science       Date:  1981-02-27       Impact factor: 47.728

9.  A cross-cultural comparison of health status values.

Authors:  D L Patrick; Y Sittampalam; S M Somerville; W B Carter; M Bergner
Journal:  Am J Public Health       Date:  1985-12       Impact factor: 9.308

10.  Weights for scoring the quality of well-being instrument among rheumatoid arthritics. A comparison to general population weights.

Authors:  D J Balaban; P C Sagi; N I Goldfarb; S Nettler
Journal:  Med Care       Date:  1986-11       Impact factor: 2.983

View more
  104 in total

1.  Managing public payment for high-cost, high-benefit treatment: enzyme replacement therapy for Gaucher's disease in Ontario.

Authors:  J T Clarke; D Amato; R B Deber
Journal:  CMAJ       Date:  2001-09-04       Impact factor: 8.262

2.  Linking the health utilities index to National Medical Expenditure Survey data.

Authors:  J A Rizzo; S Pashko; R Friedkin; J Mullahy; J L Sindelar
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

3.  Evaluating podiatry services: testing a treatment specific measure of health status.

Authors:  S Macran; P Kind; J Collingwood; R Hull; I McDonald; L Parkinson
Journal:  Qual Life Res       Date:  2003-03       Impact factor: 4.147

4.  A meta-analysis of quality-of-life estimates for stroke.

Authors:  Tammy O Tengs; Ting H Lin
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 5.  Choosing quality of care measures based on the expected impact of improved care on health.

Authors:  A L Siu; E A McGlynn; H Morgenstern; M H Beers; D M Carlisle; E B Keeler; J Beloff; K Curtin; J Leaning; B C Perry
Journal:  Health Serv Res       Date:  1992-12       Impact factor: 3.402

6.  Estimation and comparison of derived preference scores from the SF-36 in lung transplant patients.

Authors:  Francis S Lobo; Cynthia R Gross; Barbara J Matthees
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

7.  Predictors of patient self-ratings of quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study.

Authors:  Gary Naglie; David B Hogan; Murray Krahn; B Lynn Beattie; Sandra E Black; Chris Macknight; Morris Freedman; Christopher Patterson; Michael Borrie; Howard Bergman; Anna Byszewski; David Streiner; Jane Irvine; Paul Ritvo; Janna Comrie; Matthew Kowgier; George Tomlinson
Journal:  Am J Geriatr Psychiatry       Date:  2011-10       Impact factor: 4.105

Review 8.  Statistical versus quantitative significance in the socioeconomic evaluation of medicines.

Authors:  B J O'Brien; M F Drummond
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

9.  Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics.

Authors:  G W Torrance; D Blaker; A Detsky; W Kennedy; F Schubert; D Menon; P Tugwell; R Konchak; E Hubbard; T Firestone
Journal:  Pharmacoeconomics       Date:  1996-06       Impact factor: 4.981

Review 10.  Multi-attribute preference functions. Health Utilities Index.

Authors:  G W Torrance; W Furlong; D Feeny; M Boyle
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.